Release of creatine kinase, troponin-T, and tissue plasminogen activator in arterial and coronary venous blood during coronary artery bypass surgery

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 1, 1997, Pages 85-93

  Valen, G ^a   Owall A ^a   Eriksson, E ^a   Kallner, A ^a   Risberg, B ^b   Vaage, J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Cardioplegia; Endothelial injury; Myocardial injury; Tissue plasminogen activator; Troponin T

Indexed keywords

CREATINE KINASE; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HUMAN; MALE; MUSCLE INJURY; PRIORITY JOURNAL;

EID: 0030942834     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709057822     Document Type: Article

References (31)

1. Casthely PA, Mekhijan H, Yoganathan T. Cardiovascular complications following open heart surgery. In: Casthely PA, Bregman D, editors. Cardiopulmonary bypass: physiology, related complications, and pharmacology. New York: Futura Publishing Company, 1991: 299-330.
2. Katus HA, Looser S, Hallermayer K, Remppis A, Scheffold T, Borgya A, et al. Development and in vitro characterization of a new immunoassay of cardiac Troponin-T. Clin Chem 1992; 38: 386-93.
3. Mair J, Dienstl F, Puschendorf B. Cardiac Troponin-T and the diagnosis of cardiac injury. Crit Rev Clin Lab Sci 1992; 29: 31-57.
4. Vaage J, Valen G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. Scand J Thor Cardiovasc Surg 1993; Suppl. 41: 1-18.
5. Katus HA, Schoppenthau M, Tanzeem A, Bauer HG, Saggau W, Diederich KW, et al. Noninvasive assessment of perioperative myocardial cell damage by circulating cardiac Troponin-T. Br Heart J 1991; 65: 259-4.
6. Mankad PS, Chester AH, Yacoub MH. Ischaemic endothelial dysfunction after single or multidose cardioplegia. Eur Heart J 1992; 13: 976-80.
7. Pearson PJ, Lin PJ, Schaff HV. Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. J Thorac Cardiovasc Surg 1992; 103: 1147-54.
8. Lindahl S, Sørlie D, Jørgensen L. Endothelial cells of the cardiac microvasculature during and after cold cardioplegic ischemia. Comparison of endothelial and myocyte damage. Scand J Thor Cardiovasc 1988; 22: 257-65.
9. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol 1990; 16: 207-22.
10. Zilla P, von Oppell U, Deutsch M. The endothelium: a key to the future. J Cardiovasc Surg 1993; 8: 32-60.
11. Brommer EJP, Brakman P. Developments in fibrinolysis. In: Poller L, editor. Recent advances in blood coagulation 5. Edinburgh, London, Melbourne, New York and Tokyo: Churchill Livingstone, 1991: 17-34.
12. Hinsbergh VWM van. Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. Haemostasis 1988; 18: 307-27.
13. Valen G, Eriksson E, Risberg B, Vaage J. Toxic oxygen metabolites and ischemia-reperfusion injury increases release of tissue plasminogen activator from isolated rat hearts. Thromb Res 1993; 71: 113-21.
14. Valen G, Eriksson E, Risberg B, Vaage J. Fibrinolysis during cardiac surgery: Release of tissue plasminogen activator in arterial and coronary sinus blood. Eur J Cardiothorac Surg 1994; 8: 324-30.
15. Ganz W, Swan HJC. Measurement of blood flow by thermodilution. Am J Cardiol 1972; 29: 241-5.
16. Petersen IC, Handest P, Brender J, Selmer J, Jørgensen M, Thorsen S. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma. Thromb Haemost 1987; 57: 205-11.
17. Bolli R. Postischemic myocardial "stunning": pathogenesis, pathophysiology, and clinical relevance. In: Yellon DM, Jennings RB, editors. Myocardial protection. The pathophysiology of reperfusion injury. New York: Raven Press, 1992: 105-50.
18. Franco-Cereceda A, Öwall A, Settergren G, Sollevi A, Lundberg JM. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery. Cardiovasc Res 1990; 24: 242-6.
19. 2 during coronary revascularization, J Thorac Cardiovasc Surg 1987; 9: 120-6.
20. Marcus ML. Methods of measuring coronary blood flow. In: Marcus ML, editor. The coronary circulation in health and disease. New York: McGraw-Hill, 1983: 26-53.
21. Jansen NJG, Oeveren W van, Brouk L van den, Oudemans-van Straaten HM, Stoutenbeek CP, Chang NJM, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 102: 515-25.
22. Kirklin JW, Barratt-Boyes BG. Cardiac surgery. New York: Wiley, 1993.
23. Vaage J, Valen G. Could treatment with scavengers of oxygen free radicals minimize complications in cardiac surgery? Klin Wochenschr 1991; 69: 1066-72.
24. Winnerkvist A, Wiman B, Valen G, Vaage J. t-PA release during reperfusion after different times of ischemia in isolated rat hearts. Thromb Res 1996; 82: 533-42.
25. Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer AM. Time course of myocardial ischemia and reperfusion in the cat. Circulation 1990; 82:1402-12.
26. Emeis JJ. Mechanisms involved in short-term changes in blood levels of t-PA. In: Kluft T, editor. Tissue-type plasminogen activator (t-PA): physiological and clinical aspects. Vol. 2. Boca Raton, Florida: CRC Press, 1988: 21-35.
27. van den Eijnden-Schrauwen Y, Kooistra T, de Vries REM, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and from rats in vivo: evidence for a dynamic storage pool. Blood 1995; 12: 3510-17.
28. Valen G, Blomback M, Sellei P, Lindblom D, Vaage J. Release of von Willebrand Factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery. Thromb Res 1994; 73: 21-9.
29. Valen G, Sigurdardottir O, Vaage J. Systemic release of thrombomodulin, but not from the cardioplegic, reperfused heart during open heart surgery. Thromb Res 1996; 83: 321-8.
30. Semb AG, Forsdahl K, Vaage J. Granulocyte and eicosanoid gradients across the coronary circulation during myocardial reperfusion in cardiac surgery. Eur J Cardiothorac Surg 1990; 4: 543-8.
31. Wagner DD, Bonfati R. Von Willebrand Factor and the endothelium. Mayo Clin Proc 1991; 66: 621-7.